ELCC 2022 | ELCC 2022: an opportunity for discussion and new perspectives

Vera Pancaldi, PhD, Institut Universitaire du Cancer de Toulouse – Oncopole, Toulouse, France, discusses what she is most looking forward to at the European Lung Cancer Congress 2022, including the opportunity to discuss with doctors to provide new perspectives on how best to use computational tools to ultimately improve patient lives and treatment approaches. This interview took place during the virtual European Lung Cancer Congress 2022.